Cargando…

Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis

BACKGROUND: Sedation and analgesia are commonly required to relieve anxiety and pain in mechanically ventilated patients. Fentanyl and morphine are the most frequently used opioids. Remifentanil is a selective μ-opioid receptor that is metabolized by unspecific esterases and eliminated independently...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yibing, Wang, Yinhua, Du, Bin, Xi, Xiuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543734/
https://www.ncbi.nlm.nih.gov/pubmed/28774327
http://dx.doi.org/10.1186/s13054-017-1789-8
_version_ 1783255200901890048
author Zhu, Yibing
Wang, Yinhua
Du, Bin
Xi, Xiuming
author_facet Zhu, Yibing
Wang, Yinhua
Du, Bin
Xi, Xiuming
author_sort Zhu, Yibing
collection PubMed
description BACKGROUND: Sedation and analgesia are commonly required to relieve anxiety and pain in mechanically ventilated patients. Fentanyl and morphine are the most frequently used opioids. Remifentanil is a selective μ-opioid receptor that is metabolized by unspecific esterases and eliminated independently of liver or renal function. Remifentanil has a rapid onset and offset and a short context-sensitive half-life regardless of the duration of infusion, which may lead to reductions in weaning and extubation. We aimed to compare the efficacy and safety of remifentanil to that of other opioids in mechanically ventilated patients. METHODS: We conducted a search to identify relevant randomized controlled studies (RCTs) in the PubMed, Embase, Cochrane Library and SinoMed databases that had been published up to 31 December 2016. The results were analysed using weighted mean differences (WMDs) and 95% confidence intervals (CIs). RESULTS: Twenty-three RCTs with 1905 patients were included. Remifentanil was associated with reductions in the duration of mechanical ventilation (mean difference -1.46; 95% CI -2.44 to -0.49), time to extubation after sedation cessation (mean difference -1.02; 95% CI -1.59 to -0.46), and ICU-LOS (mean difference -0.10; 95% CI -0.16 to -0.03). No significant differences were identified in hospital-LOS (mean difference -0.05; 95% CI -0.25 to 0.15), costs (mean difference -709.71; 95% CI -1590.98 to 171.55; I(2) 88%), mortality (mean difference -0.64; 95% CI -1.33 to 0.06; I(2) 87%) or agitation (mean difference -0.71; 95% CI -1.80 to 0.37; I(2) 93%). CONCLUSIONS: Remifentanil seems to be associated with reductions in the duration of mechanical ventilation, time to extubation after cessation of sedation, and ICU-LOS. No significant differences were identified between remifentanil and other opioids in terms of hospital-LOS, costs, mortality or agitation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1789-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5543734
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55437342017-08-07 Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis Zhu, Yibing Wang, Yinhua Du, Bin Xi, Xiuming Crit Care Research BACKGROUND: Sedation and analgesia are commonly required to relieve anxiety and pain in mechanically ventilated patients. Fentanyl and morphine are the most frequently used opioids. Remifentanil is a selective μ-opioid receptor that is metabolized by unspecific esterases and eliminated independently of liver or renal function. Remifentanil has a rapid onset and offset and a short context-sensitive half-life regardless of the duration of infusion, which may lead to reductions in weaning and extubation. We aimed to compare the efficacy and safety of remifentanil to that of other opioids in mechanically ventilated patients. METHODS: We conducted a search to identify relevant randomized controlled studies (RCTs) in the PubMed, Embase, Cochrane Library and SinoMed databases that had been published up to 31 December 2016. The results were analysed using weighted mean differences (WMDs) and 95% confidence intervals (CIs). RESULTS: Twenty-three RCTs with 1905 patients were included. Remifentanil was associated with reductions in the duration of mechanical ventilation (mean difference -1.46; 95% CI -2.44 to -0.49), time to extubation after sedation cessation (mean difference -1.02; 95% CI -1.59 to -0.46), and ICU-LOS (mean difference -0.10; 95% CI -0.16 to -0.03). No significant differences were identified in hospital-LOS (mean difference -0.05; 95% CI -0.25 to 0.15), costs (mean difference -709.71; 95% CI -1590.98 to 171.55; I(2) 88%), mortality (mean difference -0.64; 95% CI -1.33 to 0.06; I(2) 87%) or agitation (mean difference -0.71; 95% CI -1.80 to 0.37; I(2) 93%). CONCLUSIONS: Remifentanil seems to be associated with reductions in the duration of mechanical ventilation, time to extubation after cessation of sedation, and ICU-LOS. No significant differences were identified between remifentanil and other opioids in terms of hospital-LOS, costs, mortality or agitation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1789-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-03 /pmc/articles/PMC5543734/ /pubmed/28774327 http://dx.doi.org/10.1186/s13054-017-1789-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhu, Yibing
Wang, Yinhua
Du, Bin
Xi, Xiuming
Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis
title Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis
title_full Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis
title_fullStr Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis
title_full_unstemmed Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis
title_short Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis
title_sort could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? a systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543734/
https://www.ncbi.nlm.nih.gov/pubmed/28774327
http://dx.doi.org/10.1186/s13054-017-1789-8
work_keys_str_mv AT zhuyibing couldremifentanilreducedurationofmechanicalventilationincomparisonwithotheropioidsformechanicallyventilatedpatientsasystematicreviewandmetaanalysis
AT wangyinhua couldremifentanilreducedurationofmechanicalventilationincomparisonwithotheropioidsformechanicallyventilatedpatientsasystematicreviewandmetaanalysis
AT dubin couldremifentanilreducedurationofmechanicalventilationincomparisonwithotheropioidsformechanicallyventilatedpatientsasystematicreviewandmetaanalysis
AT xixiuming couldremifentanilreducedurationofmechanicalventilationincomparisonwithotheropioidsformechanicallyventilatedpatientsasystematicreviewandmetaanalysis